Lupin 2024

the Improving Transparency and Accuracy in Medicare Part D Drug Spending Act

Controversy over DIR under Medicare Part D heats up

Controversy over DIR under Medicare Part D heats up

Direct and indirect remuneration (DIR) is one component of the complex Medicare Part D payment system. In the past several months, the issue of DIR increasingly has become a source of contention between various players in the Part D program. Pharmacies, the Centers for Medicare and Medicaid Services (CMS), and members of Congress have expressed

PP_1170x120_10-25-21